Open an account Help & support Register Account summary Log out
Skip Header
Home Stock market news

Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

National Grid sells LNG terminal to Centrica, Energy Capital for £1.5bn

Thu 14 Aug 2025 07:02

(Sharecast News) - National Grid said it had sold its Grain LNG terminal to British Gas owner Centrica and US-based Energy Capital Partners, part of Bridgepoint Group, for an enterprise value of £1.5bn.

The Isle of Grain is the UK's largest liquefied natural gas importation terminal. National Grid, which owns and operates Britain's high-voltage electricity transmission network, last year it was seeking to sell Grain as it consolidated its business.

Reporting by Frank Prenesti for Sharecast.com

Share this article

Related Sharecast Articles

Mon 13 Jul 2026 07:34
PageGroup holds guidance as Q2 profit rises on strong Americas
(Sharecast News) - Recruiter PageGroup held annual guidance after a rise in second quarter gross profit driven by a strong performance in the Americas, offsetting weaker trading in France, Northern Europe and the UK, although it warned of "a high degree of uncertainty in the outlook for the rest of the year".
Fri 10 Jul 2026 13:33
UK to regulate cloud service providers Microsoft, Google, Amazon and Oracle
(Sharecast News) - The government said on Friday that it has designated cloud service providers Microsoft, Google, Amazon and Oracle as critical third parties (CTPs), bringing them under direct regulatory oversight "to help protect the UK's financial system".
Fri 10 Jul 2026 12:16
EU warns Meta to change 'addictive Facebook, Instagram or face fine
(Sharecast News) - Tech giant Meta has been threatened with a fine if it does not change Facebook's and Instagram's "addictive" design, the European Commission said on Friday.
Fri 10 Jul 2026 11:54
GSK hails 'milestone' drug trial results in China
(Sharecast News) - A targeted lung cancer treatment developed by GSK has shown promising results in the latest trials in China, the pharma blue chip confirmed on Friday.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Policies and important information
 

Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity, Equity & Inclusion | Diversity, Equity & Inclusion Reports | Doing Business with Fidelity | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Staying secure | Statutory and Regulatory disclosures | Whistleblowing programme

 

Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document or Product Summary document which contains important information about the fund.

This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.

© FIL Limited 2026